InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
4
T+90 hit rate
20%
T+90 mean return
-10.1%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Lilly Jason Warren, Chairman & CEO. Director active across 1 company, notably NEOGEN CORP. Aggregated, 9 disclosures have been logged. Breakdown: 0 buy · 4 sells. Total volume traded: €89k. Activity tracked since 3 May 2021. The latest transaction was filed on 13 October 2023 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations9 total
351 shares@ US$15.100.7% of flowCommon StockSEC:0000711377-23-000014:0
1,917 shares@ US$15.69494.1% of flowCommon StockSEC:0000711377-23-000011:0
388 shares@ US$16.670.9% of flowCommon StockSEC:0000711377-23-000008:0
636 shares@ US$31.355.4% of flowCommon StockSEC:0000711377-21-000035
636 shares@ US$31.350.0014% mcap2.7% of flowCommon StockSEC:0000711377-21-000035:0
15,998 shares@ US$20.23130.022% mcap43.0% of flowCommon StockSEC:0000711377-21-000021:0
15,998 shares@ US$20.231340.5% of flowCommon StockSEC:0000711377-21-000021
350 shares@ US$96.730.0022% mcap4.3% of flowCommon StockSEC:0000711377-21-000018:0
350 shares@ US$96.734.3% of flowCommon StockSEC:0000711377-21-000018
9 of 9 declarations
About Lilly Jason Warren
Jason Warren Lilly is the Chairman & CEO at NEOGEN CORP. He oversees the company's operations and is responsible for international growth strategy. His role involves leading initiatives that strengthen NEOGEN's position in the global market. Through his expertise, he contributes to innovation and expansion of the company's activities.
